SCHEMBL5866015

SCHEMBL5866015

ClC1(Cl)C=Cc2ccccc2O1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 5/20 0.49
HTR2B P41595 2/20 0.49
HTT P42858 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34
MAPT P10636 3/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
UBE2N P61088 1/20 0.33
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL381889 0.77 HTR2C (0.52) HTR2CHTR2BHTTNPSR1ADRA1D
SCHEMBL29644871 0.74 HTR2C (0.49) HTR2CHTR2BHTTNPSR1MAPT
SCHEMBL1748567 0.74 HTR2C (0.49) HTR2CHTR2BHTTNPSR1MAPT
SCHEMBL11556099 0.74 HTR2C (0.49) HTR2CHTR2BHTTNPSR1ADRA1D
SCHEMBL1536905 0.74 HTR2C (0.49) HTR2CHTR2BHTTNPSR1ADRA1D
SCHEMBL6433379 0.74 HTR2C (0.49) HTR2CHTR2BHTTNPSR1ADRA1D
Ethane SCHEMBL10720474 0.72 HTR2C (0.47) HTR2CHTR2BHTTNPSR1MAPT
SCHEMBL7189873 0.72 HTR2C (0.41) HTR2CHTR2BHTTNPSR1
SCHEMBL12640789 0.71 HTR2C (0.46) HTR2CHTR2BHTTNPSR1ADRA1D
SCHEMBL8871056 0.71 HTR2C (0.46) HTR2CHTR2BHTTNPSR1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599743-A2 THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE Heuris Pharma LLC (US) 2005-11-30 EP claimed
US-20040211917-A1 Three-dimensional dosimeter for penetrating radiation and method of use HEURIS PHARMA, LLC 2004-10-28 US claimed
WO-2004079393-A2 THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE HEURIS PHARMA LLC (US) 2004-09-16 WO claimed
WO-2023211667-A1 MULTILAYER RADIOCHROMIC STRUCTURES AND USES THEREOF ISP INVESTMENTS LLC (US) 2023-11-02 WO disclosed
EP-2546679-A1 \"Three-dimensional dosimeter for penetrating radiation and method of use\ Heuris Pharma LLC (US) 2013-01-16 EP disclosed
CN-1926108-B Non-nucleotide reverse transcriptase inhibitors MEDIVIR AB 2010-06-09 CN disclosed
CN-1926108-A Non-nucleotide reverse transcriptase inhibitors MEDIVIR AB (SE) 2007-03-07 CN disclosed
US-7098463-B2 Three-dimensional dosimeter for penetrating radiation and method of use HEURIS PHARMA, LLC (US) 2006-08-29 US disclosed
EP-1599743-A2 THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE Heuris Pharma LLC (US) 2005-11-30 EP disclosed
US-20040211917-A1 Three-dimensional dosimeter for penetrating radiation and method of use HEURIS PHARMA, LLC 2004-10-28 US disclosed
WO-2004079393-A2 THREE-DIMENTIONAL DOSIMETER FOR PENETRATING RADIATION AND METHOD OF USE HEURIS PHARMA LLC (US) 2004-09-16 WO disclosed